Invited Speaker



Update time:2024-03-18 17:57

Dr. Liang Jiahe, Deputy Director of the 3D Printing Center at the Second Affiliated Hospital of the Air Force Medical University. Currently serving as a member of the 3D Printing Medical Device Professional Committee of the China Medical Device Industry Association, a member of the Shaanxi Province Additive Manufacturing (3D Printing) Medical Device Standardization Technical Committee, and the Deputy Secretary General of the Shaanxi Province 3D Printing Industry Alliance.Engaged in innovative application and research of (biological) 3D printing technology in clinical medicine, with the aim of solving clinical needs, and collaborating with clinical teams to break through medical and research technology barriers. Participated in guiding surgeries to complete 13 of the world's first 3D printed implant applications, including 3D printed titanium alloy sternum replacement surgery, 3D printed retractable funnel chest corrective titanium alloy steel plate implantation surgery, 3D printed PEEK nutcracker syndrome surgery, 3D printed degradable tracheal suspension stent implantation surgery, and congenital vaginal atresia 3D printed degradable implant vaginal reconstruction surgery. Participated in one key project and three general projects of Shaanxi Province's key research and development plan; Participated in the development of two industry standards for 3D printing medical devices in Shaanxi Province; Published four SCI papers and three Chinese core journals; Participated in the compilation of seven medical 3D printing books; Two 3D printing related application patents have been approved.

Topic title: The Development of 3D Printing in Medical Science


Medical 3D printing is an emerging medical technology that closely integrates advanced technologies such as digitization, intelligence, and visualization with medical practice, providing personalized and accurate medical services for diagnosis, treatment, rehabilitation, and other links in the medical field. 3D printing technology has shown infinite possibilities in clinical applications, and its important significance and broad prospects are not only reflected in meeting personalized treatment needs and customizing high-end medical devices, but also in the gradual manifestation of its profound impact.

3D printing personalized customized medical devices not only successfully solves the problem of traditional surgical adaptability, but also provides more accurate and effective treatment plans for clinical doctors. 3D printing technology has also driven significant development in the fields of medical education and training. By using 3D printed models for simulation training, medical students and doctors can repeatedly practice in a safe environment, improve their surgical skills and anatomical knowledge level, thereby minimizing intraoperative risks and providing a new way and space for medical staff training. In addition, bioprinting technology has brought revolutionary changes to the medical field. With the help of bioprinting technology, researchers have successfully printed various prototypes of human tissues and organs, providing unlimited possibilities for future organ transplantation and regenerative medicine. The breakthrough in this technology will completely change the difficult situation of traditional organ transplantation and provide patients with more reliable and effective treatment methods.

With the continuous progress of science and technology, we have reason to believe that 3D printing technology will continue to drive the medical field towards precision, personalization, and intelligence, bringing more surprises and hope to the cause of human health. The development of this technology will not only improve the level of medical services, but also profoundly change the overall pattern of the medical industry, making medical technology closer to human dreams and expectations.

Congress has ended
Important Dates
Conference Dates
March 29-31, 2024
Deadline for Submission of Abstract

December 31, 2023

Still open for submission

Notification of Abstract Acceptance

January 15, 2024

January 25, 2024